A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

August 31, 2007

Conditions
Dry Eye
Interventions
DRUG

doxycycline

DRUG

placebo

Trial Locations (1)

01810

Ophthalmic Research Associates, Andover

Sponsors
All Listed Sponsors
lead

Alacrity Biosciences, Inc.

INDUSTRY

NCT00439400 - A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period | Biotech Hunter | Biotech Hunter